Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 2006, p. 4177-4181, Vol. 50, No. 12
0066-4804/06/$08.00+0 doi:10.1128/AAC.00619-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Université Paris VI, UPRES EA 2392, UFR de Médecine Pierre et Marie Curie, Paris, France,1 AP-HP, Hôpital Tenon, Service de Bactériologie, Paris, France,2 AP-HP, Hôpital Raymond Poincaré, Laboratoire de Microbiologie, Garches, France,3 Service de Microbiologie, CHU Habib Bourguiba, Sfax, Tunisia,4 AP-HP, Hôpital Cochin, Service de Bactériologie, Paris, France5
Received 19 May 2006/ Returned for modification 8 July 2006/ Accepted 6 September 2006
|
|
|---|
|
|
|---|
ACC-1 was characterized in isolates of several species, such as Klebsiella pneumoniae, Proteus mirabilis, Salmonella enterica, and Escherichia coli, from Germany, France, Tunisia, Spain, and The Netherlands (2, 3, 6-9, 11, 12, 15). In France, nosocomial outbreaks following the admission of a patient transferred from Tunisia, a country which seems to be a potential reservoir, were described (11, 12).
The ACC-1-producing rifampin-resistant K. pneumoniae SLK54 strain, isolated in Saint-Louis Hospital in Paris, France, was previously studied by cloning experiments, and the genetic organizations of both plasmid-mediated genes, blaACC-1 and arr-2, were established (1, 11). The presence of IS26 in both recombinant plasmids suggests that arr-2 and blaACC-1 could be linked in the K. pneumoniae SLK54 plasmid. In this study, we have tested this hypothesis, and we have analyzed the genetic environment of the blaACC-1 gene in a collection of ACC-1-producing isolates, including 11 K. pneumoniae, one P. mirabilis, and two S. enterica isolates from different settings.
Table 1 lists the 14 clinical isolates and their sources. Most isolates were previously studied (2, 8, 11, 12, 15).
|
View this table: [in a new window] |
TABLE 1. Origin, epidemiological features, and PCR mapping of clinical isolates
|
By mating experiments, E. coli K-12 J53-2 or E. coli K-12 HB101 transconjugants were obtained with ceftazidime (10 µg/ml) and either rifampin (250 µg/ml) or streptomycin (250 µg/ml) as selective agents. In case of failure, plasmid DNA was used to transform E. coli DH10B cells by electroporation (Bio-Rad). Transformants were selected with ceftazidime (10 µg/ml). Fingerprinting analysis was carried out with plasmid DNA purified from transformants or transconjugants by using a plasmid midi kit (QIAGEN, Courtaboeuf, France), digested with EcoRI, and subjected to electrophoresis in a 1.2% agarose gel at 80 V for 3 h. This analysis showed that plasmids present in the 10 French isolates were identical to those in the Tunisian K. pneumoniae isolate C5900 (profile A) (data not shown). Each of the other three isolates had unique plasmid profiles (Table 1). It seems that the spread of blaACC-1 in three different hospitals in France is linked to the spread of both a clonal strain and a plasmid that likely originated from Tunisia.
PCR experiments and DNA sequencing were carried out with the clinical isolates to detect blaTEM, as previously described (17), and blaACC (Table 2 PCR A). The sequence analysis showed that, except for S. enterica serovar Mbandaka MMAS40, all isolates were TEM-1 positive (data not shown), and it confirmed that all isolates and transformants or transconjugants were ACC-1-positive.
|
View this table: [in a new window] |
TABLE 2. Sequences of oligonucleotides used for PCR mapping
|
![]() View larger version (25K): [in a new window] |
FIG. 1. Comparison of regions surrounding blaACC-1. ORF, open reading frame.
|
Common structures. The ACC-1-producing isolates all have the same genetic organization of plasmid-encoded blaACC-1 in the proximity of the ß-lactamase gene. In each isolate, a 1,318-bp region originating from the H. alvei chromosome, comprising ampC but lacking ampR (which is consistent with the high level of ß-lactamase production), was present. The total length of the sequence mobilized from H. alvei is unknown, as the previously sequenced region surrounding the ampC and ampR genes from H. alvei (accession number AF180952) is too short, with only the final 18-bp segment of gdha being present in this sequence. Nevertheless, gdha is present downstream from blaACC-1 in H. alvei (PCRs A and B) (Table 1) and in the six plasmid-carried blaACC-1 genetic organization profiles. Moreover, gdha, which encodes a glutamate dehydrogenase, is a very common housekeeping gene among proteobacteria, and its presence on the H. alvei genome would be expected. Thus, the gdha sequence present downstream from blaACC-1 is presumed to have been mobilized from the H. alvei chromosome together with blaACC-1.
The insertion sequence ISEcp1 upstream from blaACC-1 is always present in the same orientation but has variable deletions in the 5' part: a 1,433-bp deletion for SLK54 and SLK55; a 1,101-bp deletion for KUS, B952, and MMAS40; and a 988-bp deletion for S. enterica serovar Bareilly 60.50. Nevertheless, the length between the end of ISEcp1 and the ATG codon of blaACC-1 is constant, which suggests that only one genetic recombination event has occurred. ISEcp1 is known to be involved in both the mobilization and expression of blaCTX-M ß-lactamase genes (14). Although ISEcp1 is always truncated in the 5' part and can no longer function in transposition events, we cannot rule out the possibility that it was involved in the initial mobilization of blaACC-1 in an ancestor common to the six different profiles described here. Indeed, ISEcp1 transposase may recognize a wide range of DNA sequences as inverted right repeats and use them as ends in a mobilization process involving its adjacent sequences (14). The 35 and 10 regions corresponding to putative promoter sequences for acquired bla were different for the chromosomal blaACC type of H. alvei. Indeed, whatever the deletion of ISEcp1, the promoter is likely provided by ISEcp1, as reported with blaCTX-M (4).
Different structures. The genetic organization of plasmid-carried blaACC-1 differs beyond ISEcp1 and gdha, and it can be divided into three main patterns.
(i) the first pattern was found in SLK54 and in the related isolates SLK55 and C5900. In this pattern, ISEcp1 has a 1,433-bp deletion due to an insertion of an IS26 in the opposite orientation. A second copy of IS26 (IS26L) is present 4,210 bp upstream from the first copy, IS26R. The two copies of IS26 are in opposite orientations, with the 3' ends facing outwards (Fig. 1). Another copy of ISEcp1 (ISEcp1L) is present downstream from IS26L and is 3' truncated, with the deletion being exactly complementary to that of ISEcp1R upstream from blaACC-1. This and the presence of two copies of IS26 suggest that a composite transposon with two directly repeated IS26s was inserted in ISEcp1 with the duplication of a 8-bp target site (characteristic of IS26 transposition) GACATTTT (10). However, we are still unsure as to how ISEcp1L and IS26L could have been secondarily inverted and moved elsewhere, downstream from blaACC-1.
(ii) The second pattern was found in KUS, B952, and MMAS40. In this group, ISEcp1 has a 1,101-bp deletion due to the insertion of an IS26 in the same orientation. A second copy of IS26 (IS26L) is present 2,742 bp downstream from blaACC-1 (Fig. 1). The two copies of IS26 are in opposite orientations, with the 3' ends facing inwards. The DNA sequence between the two copies of IS26 is 100% identical in KUS, B952, and MMAS40. Beyond IS26, the DNA sequence was different in the three structures (Fig. 1). Thus, the structures from the KUS, B952, and MMAS40 isolates are likely derived from a common ancestor different from that of the first pattern, with a shorter deletion of ISEcp1 due to the insertion of IS26 in the opposite direction. After this event, several different genetic events seem to have occurred, mainly involving Tn1696 but also involving a class 1 integron carrying a dfrA21 gene cassette.
(iii) The third pattern was observed in S. enterica serovar Bareilly only (Fig. 1). This has an ISEcp1 deleted by 988 bp due to the insertion of the previously described orf7 (7). The 309-amino-acid protein encoded by orf7 is 99% identical to a transposase described for Yersinia enterocolitica strain 29979 (GenBank accession number CAA73750). Upstream from gdha, the three previously described open reading frames encode proteins, the first identical to a transposase from K. pneumoniae CG43 (accession number NP_943502), the second identical to a protein from the Y. enterocolitica plasmid p29930 (GenBank accession number CAD58550), and the third identical to a recombinase from the same plasmid (GenBank accession number CAE46772).
Studies of the molecular mechanisms of ampC gene transfer from chromosome to plasmids are in progress. It seems that several different DNA-mobilizing elements, such as common regions associated to integrons and insertion sequences, are involved in the movement of the ampC gene and the adjacent region (13, 17). Although IS26 has been found in the genetic organization of blaACC-1 in several clinical isolates, it is likely that this structure is not directly involved in the translocation of the ampC gene from the H. alvei chromosome to different plasmids. Nevertheless, its presence seems to be linked with recombination events occurring after the insertion of ISEcp1 upstream from blaACC-1 that lead to the deletion of the 5' end of ISEcp1 (Fig. 1). In all cases, ISEcp1 was never complete, and its deletion may have led to the stabilization of blaACC-1 on different plasmids.
Nucleotide sequence accession numbers. The nucleotide sequences in strains SLK54, SLK55, KUS, B952, and MMAS40 have been submitted to GenBank and have been assigned accession numbers AJ870923, AJ870922, AJ870924, AJ870925, and AJ870926, respectively.
Published ahead of print on 18 September 2006. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»